Vericel Historical Financial Ratios
| VCEL Stock | USD 57.31 0.27 0.47% |
Vericel Corp is promptly reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 8.15, Dividend Yield of 0.0, PTB Ratio of 3.9 or Days Sales Outstanding of 79.55 will help investors to properly organize and evaluate Vericel Corp Ord financial condition quickly.
Vericel |
About Vericel Financial Ratios Analysis
Vericel Corp OrdFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Vericel Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Vericel financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Vericel Corp history.
Vericel Corp Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Vericel Corp Ord stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Vericel Corp sales, a figure that is much harder to manipulate than other Vericel Corp Ord multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Return On Assets
A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.Most ratios from Vericel Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. At this time, Vericel Corp's Capex To Operating Cash Flow is quite stable compared to the past year. PFCF Ratio is expected to rise to 228.19 this year, although the value of PTB Ratio will most likely fall to 3.90.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 5.56 | 3.22 | 2.77 | 1.94 | Days Of Inventory On Hand | 97.37 | 106.91 | 77.12 | 73.26 |
Vericel Corp fundamentals Correlations
Click cells to compare fundamentals
Vericel Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vericel Corp fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 6.52 | 11.25 | 11.69 | 7.55 | 8.58 | 8.15 | |
| Ptb Ratio | 6.92 | 10.4 | 10.71 | 6.46 | 7.5 | 3.9 | |
| Days Sales Outstanding | 99.63 | 101.42 | 87.49 | 103.35 | 107.84 | 79.55 | |
| Book Value Per Share | 2.51 | 2.97 | 3.67 | 4.08 | 4.75 | 4.51 | |
| Free Cash Flow Yield | (0.0127) | 0.0107 | 0.0116 | 0.008129 | 0.004601 | 0.004832 | |
| Operating Cash Flow Per Share | (0.16) | 0.39 | 0.62 | 0.38 | 0.74 | 0.78 | |
| Stock Based Compensation To Revenue | 0.0419 | 0.0795 | 0.11 | 0.22 | 0.23 | 0.16 | |
| Pb Ratio | 6.92 | 10.4 | 10.71 | 6.46 | 7.5 | 3.9 | |
| Ev To Sales | 6.53 | 11.4 | 11.58 | 7.53 | 8.68 | 8.24 | |
| Free Cash Flow Per Share | (0.22) | 0.33 | 0.45 | 0.21 | 0.16 | 0.17 | |
| Roic | (0.0829) | 0.004674 | (0.0454) | (0.0927) | (0.0374) | (0.0393) | |
| Inventory Turnover | 5.51 | 4.27 | 3.75 | 3.41 | 4.73 | 3.7 | |
| Net Income Per Share | (0.18) | 0.0633 | (0.16) | (0.35) | (0.0669) | (0.0702) | |
| Days Of Inventory On Hand | 66.22 | 85.48 | 97.37 | 106.91 | 77.12 | 73.26 | |
| Payables Turnover | 5.92 | 5.91 | 5.56 | 3.22 | 2.77 | 1.94 | |
| Research And Ddevelopement To Revenue | 0.2 | 0.15 | 0.26 | 0.1 | 0.12 | 0.11 | |
| Capex To Revenue | 0.0222 | 0.0211 | 0.0507 | 0.0462 | 0.14 | 0.13 | |
| Cash Per Share | 1.58 | 1.68 | 2.22 | 2.54 | 2.3 | 2.19 | |
| Pocfratio | (107.02) | 79.47 | 62.89 | 70.19 | 47.99 | 50.39 | |
| Interest Coverage | (1.4K) | 111.17 | (2.0K) | (46.61) | (10.77) | (11.31) | |
| Capex To Operating Cash Flow | (0.36) | 0.15 | 0.27 | 0.43 | 0.78 | 0.82 | |
| Pfcf Ratio | (78.45) | 93.43 | 86.45 | 123.02 | 217.32 | 228.19 | |
| Days Payables Outstanding | 61.64 | 61.71 | 65.61 | 113.22 | 131.69 | 125.1 | |
| Income Quality | 0.74 | 6.14 | (3.89) | (1.06) | (11.1) | (10.54) | |
| Roe | (0.0712) | 0.0213 | (0.0438) | (0.0869) | (0.0141) | (0.0148) | |
| Ev To Operating Cash Flow | (107.13) | 80.58 | 62.26 | 69.99 | 48.53 | 50.96 | |
| Pe Ratio | (97.2) | 487.58 | (244.46) | (74.3) | (532.58) | (505.95) | |
| Return On Tangible Assets | (0.0516) | 0.0139 | (0.0307) | (0.0629) | (0.009176) | (0.009635) | |
| Ev To Free Cash Flow | (78.53) | 94.74 | 85.59 | 122.67 | 219.77 | 230.75 | |
| Earnings Yield | (0.0103) | 0.002051 | (0.004091) | (0.0135) | (0.001878) | (0.001972) | |
| Net Debt To E B I T D A | (0.16) | 1.98 | 3.95 | 0.3 | 6.65 | 6.99 | |
| Current Ratio | 5.64 | 5.5 | 6.08 | 4.99 | 4.49 | 4.27 | |
| Tangible Book Value Per Share | 2.51 | 2.97 | 3.67 | 3.92 | 4.6 | 4.37 | |
| Receivables Turnover | 3.66 | 3.6 | 4.17 | 3.53 | 3.38 | 3.22 | |
| Graham Number | 3.18 | 2.06 | 3.64 | 5.7 | 2.67 | 2.54 | |
| Shareholders Equity Per Share | 2.51 | 2.97 | 3.67 | 4.08 | 4.75 | 4.51 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share 0.08 | Revenue Per Share 4.685 | Quarterly Revenue Growth 0.27 | Return On Assets (0) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.